Updated Jul 16, 2026
Doshi Dipal is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 19.2K | $11.76 | $225K |
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 9.9K | $11.66 | $115K |
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | A — Grant or award | 139.4K | $0.00 | |
| 2026-02-06 | AZTA | Azenta, Inc. | A — Grant or award | 5.7K | $27.85 | $158K |
| 2025-09-02 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 8.7K | $5.43 | $47K |
Doshi Dipal is a corporate insider — currently tracked as CEO, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Doshi Dipal profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.